These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34218099)

  • 1. Lessons for and from the COVID-19 pandemic response - An appraisal of guidance for the public health management of Invasive Meningococcal Disease.
    Morello BR; Milazzo A; Marshall HS; Giles LC
    J Infect Public Health; 2021 Aug; 14(8):1069-1074. PubMed ID: 34218099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health management of invasive meningococcal disease in Baden-Wuerttemberg, Germany, 2012: adherence to guidance and estimation of resources required as determined in a survey of local health authorities.
    Murajda L; Aichinger E; Pfaff G; Hellenbrand W
    BMC Public Health; 2015 Apr; 15():371. PubMed ID: 25881238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European public health policies for managing contacts of invasive meningococcal disease cases better harmonised in 2013 than in 2007.
    Vygen S; Hellenbrand W; Stefanoff P; Hanquet G; Heuberger S; Stuart J
    Euro Surveill; 2016; 21(5):23-31. PubMed ID: 26875517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary meningococcal conjunctivitis: Summary of evidence for the clinical and public health management of cases and close contacts.
    Parikh SR; Campbell H; Mandal S; Ramsay ME; Ladhani SN
    J Infect; 2019 Dec; 79(6):490-494. PubMed ID: 31669376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Did social distancing measures deployed for SARS-CoV-2/COVID-19 control have an impact on invasive meningococcal disease?
    Stefanelli P; Fazio C; Vacca P; Neri A; Ambrosio L; Rezza G
    Pathog Glob Health; 2022 Jun; 116(4):263-265. PubMed ID: 34844520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of meningococcal outbreaks: are we using the same language? Comparison of the public health policies between high-income countries with low incidence of meningococcal disease.
    Burmaz T; Guicciardi S; Selle V; Lopalco PL; Baldo V; Fantini MP
    Expert Rev Vaccines; 2019 May; 18(5):559-574. PubMed ID: 30875482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.
    Subbarao S; Campbell H; Ribeiro S; Clark SA; Lucidarme J; Ramsay M; Borrow R; Ladhani S
    Emerg Infect Dis; 2021 Sep; 27(9):2495-2497. PubMed ID: 34193335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal infections among refugees and immigrants: silent threats of past, present and future.
    Dinleyici EC; Borrow R
    Hum Vaccin Immunother; 2020 Nov; 16(11):2781-2786. PubMed ID: 32347773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease.
    Taha MK; Deghmane AE
    BMC Res Notes; 2020 Aug; 13(1):399. PubMed ID: 32854773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serogroup B invasive meningococcal disease (IMD) outbreak at a Japanese high school dormitory: An outbreak investigation report from the first IMD outbreak in decades.
    Sekiya N; Sunagawa T; Takahashi H; Kamiya H; Yoshino S; Ohnishi M; Okabe N; Taniguchi K
    Vaccine; 2021 Apr; 39(15):2177-2182. PubMed ID: 33736919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive meningococcal disease in the Veneto region of Italy: a capture-recapture analysis for assessing the effectiveness of an integrated surveillance system.
    Baldovin T; Lazzari R; Cocchio S; Furlan P; Bertoncello C; Saia M; Russo F; Baldo V
    BMJ Open; 2017 May; 7(4):e012478. PubMed ID: 28465304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review.
    Dagens A; Sigfrid L; Cai E; Lipworth S; Cheng V; Harris E; Bannister P; Rigby I; Horby P
    BMJ; 2020 May; 369():m1936. PubMed ID: 32457027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of a second MenB vaccine into Europe - needs and opportunities for public health.
    Findlow J; Nuttens C; Kriz P
    Expert Rev Vaccines; 2019 Mar; 18(3):225-239. PubMed ID: 30821535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management in the paediatric wards facing novel coronavirus infection: a rapid review of guidelines and consensuses.
    Luo WY; Sun JW; Zhang WL; Li Q; Ni P; Zhao LB; Tian JH; Zhang YQ; Lu H
    BMJ Open; 2020 Aug; 10(8):e039897. PubMed ID: 32788192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in Neisseria meningitidis infection in Italy after Meningococcal C conjugate vaccine introduction: A time trend analysis of 1994-2012 series.
    de Waure C; Miglietta A; Nedovic D; Mereu G; Ricciardi W
    Hum Vaccin Immunother; 2016; 12(2):467-73. PubMed ID: 26308192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern Europe.
    Bai X; Borrow R; Bukovski S; Caugant DA; Culic D; Delic S; Dinleyici EC; Eloshvili M; Erdősi T; Galajeva J; Křížová P; Lucidarme J; Mironov K; Nurmatov Z; Pana M; Rahimov E; Savrasova L; Skoczyńska A; Smith V; Taha MK; Titov L; Vázquez J; Yeraliyeva L
    J Infect; 2019 Dec; 79(6):528-541. PubMed ID: 31682877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context.
    Dubey AP; Hazarika RD; Abitbol V; Kolhapure S; Agrawal S
    Hum Vaccin Immunother; 2021 Jul; 17(7):2216-2224. PubMed ID: 33605845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.
    Hellenbrand W; Koch J; Harder T; Bogdan C; Heininger U; Tenenbaum T; Terhardt M; Vogel U; Wichmann O; von Kries R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1314-43. PubMed ID: 26487381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.